| Today, Mon, Nov 9, 2009 | | • | [$$] Bumpy Road for Medical Supplies and Devices
at Barrons.com (Mon 2:59pm)
| | • | Covidien closes in on Aspect buyout
at bizjournals.com (Mon 11:05am)
| | • | Covidien adds kidney risk to Optimark label
AP (Mon 10:46am)
| | • | InPlay: Covidien submits label change for Optimark contrast agent
Briefing.com (Mon 8:05am)
| | • | Covidien Submits Label Change for Optimark Contrast Agent
Business Wire (Mon 8:00am)
| | Sun, Nov 8, 2009 | | • | The Stock Screaming "Buy Me!"
at Motley Fool (Sun 9:00am)
| | Fri, Nov 6, 2009 | | • | COVIDIEN PLC Files SEC form 8-K, Other Events, Financial Statements and Exhibits
EDGAR Online (Fri, Nov 6)
| | • | Covidien closes $210M purchase of Aspect Medical
AP (Fri, Nov 6)
| | • | Covidien Completes Acquisition of Aspect Medical Systems Inc.
Business Wire (Fri, Nov 6)
| | • | Covidien Successfully Completes Tender Offer for Shares of Aspect Medical Systems, Inc.
Business Wire (Fri, Nov 6)
| | Thu, Nov 5, 2009 | | • | UPDATE - Nuvo shares surge on FDA pain cream approval
at Reuters (Thu, Nov 5)
| | • | FDA Approves Pennsaid® Topical Solution
Business Wire (Thu, Nov 5)
| | Wed, Nov 4, 2009 | | • | Covidien to Present at Credit Suisse Healthcare Conference
Business Wire (Wed, Nov 4)
| | Tue, Nov 3, 2009 | | • | How Covidien Reinvented Itself and Thrived
at BusinessWeek (Tue, Nov 3)
| | Mon, Nov 2, 2009 | | • | [$$] 13D Filings
at Barrons.com (Mon, Nov 2)
| | • | Chevron: Analysts' Upgrades, Downgrades
at TheStreet.com (Mon, Nov 2)
| | Fri, Oct 30, 2009 | | • | Covidien gets approval for generic pain drug Actiq
AP (Fri, Oct 30)
| | • | Covidien Receives FDA Approval for Oral Transmucosal Fentanyl Citrate Product
Business Wire (Fri, Oct 30)
| | • | Now's a Great Time to Invest -- So Don't Blow It Like This
at Motley Fool (Fri, Oct 30)
| | Wed, Oct 28, 2009 | | • | 'Fast Money' Recap: Market Slide
at TheStreet.com (Wed, Oct 28)
|
Add COV News to My Yahoo!:
 
| |
|
2.03% Nasdaq 
Headlines
